{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:06:25Z","timestamp":1790197585268,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Xention Limited, Cambridge, United Kingdom"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10840-018-0318-2","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T08:42:56Z","timestamp":1519029776000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy"],"prefix":"10.1007","volume":"51","author":[{"given":"S. R.","family":"Shunmugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conn","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Freemantle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Round","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Furniss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Sulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"1","key":"318_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2296-13-106","volume":"13","author":"L\u00c1 P\u00e9rula-de-Torres","year":"2012","unstructured":"P\u00e9rula-de-Torres L\u00c1, et al. Opportunistic Detection of Atrial Fibrillation in Subjects Aged 65 Years or Older in Primare Care: A Randomised Clinical Trial of Efficacy. DOFA-AP Study Protocol. BMC Family Practice. 2012;13(1):106. \n                    https:\/\/doi.org\/10.1186\/1471-2296-13-106\n                    \n                  .","journal-title":"BMC Family Practice"},{"issue":"10","key":"318_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/eurheartj\/eht027","volume":"34","author":"AJ Camm","year":"2013","unstructured":"Camm AJ, Lip GYH, de Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation\u2019 [Eur Heart J (2012); 33(21):2719-2747]. Eur Heart J. 2013;34(10):790. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht027\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"4","key":"318_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.amjmed.2006.06.042","volume":"120","author":"Y Miyasaka","year":"2007","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Seward JB, et al. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med. 2007;120(4):357\u201363. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2006.06.042\n                    \n                  .","journal-title":"Am J Med"},{"issue":"9506","key":"318_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(06)68037-9","volume":"367","author":"S Nattel","year":"2006","unstructured":"Nattel S, Opie LH. Controversies in atrial fibrillation. Lancet. January 21, 2006;367(9506):262\u201372. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(06)68037-9\n                    \n                  .","journal-title":"Lancet"},{"issue":"suppl 4","key":"318_CR5","doi-asserted-by":"publisher","first-page":"iv37","DOI":"10.1093\/europace\/eum169","volume":"9","author":"E Shantsila","year":"2007","unstructured":"Shantsila E, Watson T, Lip GYH. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. Europace. 2007;9(suppl 4):iv37\u201344. \n                    https:\/\/doi.org\/10.1093\/europace\/eum169\n                    \n                  .","journal-title":"Europace"},{"issue":"8","key":"318_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jacc.2007.08.067","volume":"51","author":"JR Ehrlich","year":"2008","unstructured":"Ehrlich JR, Biliczki P, Hohnloser SH, Nattel S. Atrial-selective approaches for the treatment of atrial fibrillation. J Am Coll Cardiol. 2008;51(8):787\u201392. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2007.08.067\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"318_CR7","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1161\/01.CIR.91.5.1588","volume":"91","author":"CA Morillo","year":"1995","unstructured":"Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588\u201395. \n                    https:\/\/doi.org\/10.1161\/01.CIR.91.5.1588\n                    \n                  .","journal-title":"Circulation"},{"issue":"6416","key":"318_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/362127a0","volume":"362","author":"Y Kubo","year":"1993","unstructured":"Kubo Y, Baldwin TJ, Nung Jan Y, Jan LY. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature. 1993;362(6416):127\u201333. \n                    https:\/\/doi.org\/10.1038\/362127a0\n                    \n                  .","journal-title":"Nature"},{"issue":"5","key":"318_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/europace\/eup097","volume":"11","author":"Task Force Members","year":"2009","unstructured":"Task Force Members, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11(5):671\u201387. \n                    https:\/\/doi.org\/10.1093\/europace\/eup097\n                    \n                  .","journal-title":"Europace"},{"issue":"6","key":"318_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/01.RES.73.6.1061","volume":"73","author":"Z Wang","year":"1993","unstructured":"Wang Z, Fermini B, Nattel S. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circ Res. 1993;73(6):1061\u201376. \n                    https:\/\/doi.org\/10.1161\/01.RES.73.6.1061\n                    \n                  .","journal-title":"Circ Res"},{"issue":"4","key":"318_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/01.RES.78.4.689","volume":"78","author":"G-R Li","year":"1996","unstructured":"Li G-R, Feng J, Yue L, Carrier M, Nattel S. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ Res. 1996;78(4):689\u201396. \n                    https:\/\/doi.org\/10.1161\/01.RES.78.4.689\n                    \n                  .","journal-title":"Circ Res"},{"issue":"1","key":"318_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1172\/JCI118032","volume":"96","author":"DJ Mays","year":"1995","unstructured":"Mays DJ, et al. Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue. The Journal of Clinical Investigation. 1995;96(1):282\u201392. \n                    https:\/\/doi.org\/10.1172\/JCI118032\n                    \n                  .","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"318_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0008-6363(99)00034-6","volume":"42","author":"M Courtemanche","year":"1999","unstructured":"Courtemanche M, Ramirez RJ, Nattel S. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. Cardiovasc Res. 1999;42(2):477\u201389. \n                    https:\/\/doi.org\/10.1016\/S0008-6363(99)00034-6\n                    \n                  .","journal-title":"Cardiovasc Res"},{"issue":"16","key":"318_CR14","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/01.CIR.0000145155.60288.71","volume":"110","author":"E Wettwer","year":"2004","unstructured":"Wettwer E, H\u00e1la O, Christ T, Heubach JF, Dobrev D, Knaut M, et al. Role of IKur in controlling action potential shape and contractility in the human atrium influence of chronic atrial fibrillation. Circulation. 2004;110(16):2299\u2013306. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000145155.60288.71\n                    \n                  .","journal-title":"Circulation"},{"issue":"2","key":"318_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/FJC.0b013e3181719b0c","volume":"52","author":"JW Ford","year":"2008","unstructured":"Ford JW, Milnes JT. New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value. J Cardiovasc Pharmacol. 2008;52(2):105\u201320. \n                    https:\/\/doi.org\/10.1097\/FJC.0b013e3181719b0c\n                    \n                  .","journal-title":"J Cardiovasc Pharmacol"},{"issue":"12","key":"318_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.106.630905","volume":"114","author":"S Haan de","year":"2006","unstructured":"de Haan S, et al. AVE0118, blocker of the transient outward current (Ito) and ultrarapid delayed rectifier current (IKur), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat. Circulation. 2006;114(12):1234\u201342. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.630905\n                    \n                  .","journal-title":"Circulation"},{"issue":"8","key":"318_CR17","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/bjp.2008.209","volume":"154","author":"T Christ","year":"2008","unstructured":"Christ T, Wettwer E, Voigt N, H\u00e1la O, Radicke S, Matschke K, et al. Pathology-specific effects of the IKur\/Ito\/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation. Br J Pharmacol. 2008;154(8):1619\u201330. \n                    https:\/\/doi.org\/10.1038\/bjp.2008.209\n                    \n                  .","journal-title":"Br J Pharmacol"},{"issue":"4","key":"318_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1527-3466.2007.00025.x","volume":"25","author":"H Tanaka","year":"2007","unstructured":"Tanaka H, Hashimoto N. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation. Cardiovasc Drug Rev. 2007;25(4):342\u201356. \n                    https:\/\/doi.org\/10.1111\/j.1527-3466.2007.00025.x\n                    \n                  .","journal-title":"Cardiovasc Drug Rev"},{"issue":"5","key":"318_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/CIRCEP.111.962340","volume":"4","author":"C Torp-Pedersen","year":"2011","unstructured":"Torp-Pedersen C, Raev DH, Dickinson G, Butterfield NN, Mangal B, Beatch GN. A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion. Circ Arrhythm Electrophysiol. 2011;4(5):637\u201343. \n                    https:\/\/doi.org\/10.1161\/CIRCEP.111.962340\n                    \n                  .","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"318_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1540-8167.2005.50028.x","volume":"16","author":"D Fedida","year":"2005","unstructured":"Fedida D, et al. The mechanism of atrial antiarrhythmic action of RSD1235. J Cardiovasc Electrophysiol. 2005;16(11):1227\u201338. \n                    https:\/\/doi.org\/10.1111\/j.1540-8167.2005.50028.x\n                    \n                  .","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"318_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCEP.109.884429","volume":"2","author":"PK Mason","year":"2009","unstructured":"Mason PK, DiMarco JP. New pharmacological agents for arrhythmias. Circ Arrhythm Electrophysiol. 2009;2(5):588\u201397. \n                    https:\/\/doi.org\/10.1161\/CIRCEP.109.884429\n                    \n                  .","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-018-0318-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T01:15:13Z","timestamp":1550538913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-018-0318-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1007\/s10840-018-0318-2","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"3 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the National Research Ethics Service South East Coast - Brighton and Sussex Ethics Committee. The study was conducted in compliance with International Conference on Harmonisation (ICH) good clinical practice (GCP) guidelines and all relevant local regulatory requirements and laws, and all patients gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Funding support is from XENTION Limited, Cambridge, UK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}